Literature DB >> 17704808

Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling.

S-G Lee1, Z-Z Su, L Emdad, D Sarkar, T F Franke, P B Fisher.   

Abstract

Astrocyte elevated gene-1 (AEG-1) displays oncogenic properties. Its expression is elevated in diverse neoplastic states and it cooperates with Ha-ras to promote cellular transformation. Overexpression of AEG-1 augments invasion and anchorage-independent growth of transformed cells, while AEG-1 siRNA inhibits Ha-ras-mediated colony formation, supporting a potential functional role in tumorigenesis. Additionally, oncogenic Ha-ras induces AEG-1 expression through the phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway. In the present study, we investigated whether AEG-1 could induce serum-independent cell growth, another property of oncogenes. Overexpression of AEG-1 inhibited serum starvation-induced apoptosis through activation of PI3K-Akt signaling, one of the effector pathways induced by activated Ras. AEG-1 also affected the phosphorylation state of Akt substrates that are implicated in apoptosis suppression, including glycogen synthase kinase 3beta, c-Myc, murine double minute 2, p53, p21/mda-6 and Bad. Additionally, AEG-1 blocked the activity of serum starvation-induced caspases. Taken together, these observations provide evidence that AEG-1 is an oncogene cooperating with Ha-ras as well as functioning as a downstream target gene of Ha-ras and may perform a central role in Ha-ras-mediated carcinogenesis. Activation of survival pathways may be one mechanism by which AEG-1 exerts its oncogenic properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17704808     DOI: 10.1038/sj.onc.1210713

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  107 in total

1.  The cellular protein lyric interacts with HIV-1 Gag.

Authors:  Christine E Engeland; Heike Oberwinkler; Michael Schümann; Eberhard Krause; Gerd A Müller; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  Knockdown of Astrocyte Elevated Gene-1 Inhibits Activation of Hepatic Stellate Cells.

Authors:  Lei Chen; Yong-Ze Guo; Ai-di Li; Jun-Ji Ma; Hui-Yao Hao; Di Zhang; Yan Wang; Chen-Guang Ji; Wei Qi; Jia Wang; Hui-Qing Jiang
Journal:  Dig Dis Sci       Date:  2016-02-15       Impact factor: 3.199

3.  Depletion of astrocyte elevated gene-1 suppresses tumorigenesis through inhibition of Akt activity in bladder cancer cells.

Authors:  Lianhua Zhang; Guoliang Yang; Haige Chen; Yiran Huang; Wei Xue; Juanjie Bo
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

Review 4.  AEG-1/MTDH/LYRIC in liver cancer.

Authors:  Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

Review 5.  The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

Authors:  Evan K Noch; Kamel Khalili
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

6.  Upregulation of AEG-1 Involves in Schwann Cell Proliferation and Migration After Sciatic Nerve Crush.

Authors:  Youhua Wang; Weidong Zhang; Xudong Zhu; Yi Wang; Xingxing Mao; Xinbao Xu; Youhua Wang
Journal:  J Mol Neurosci       Date:  2016-06-28       Impact factor: 3.444

7.  Metadherin contribute to BCR signaling in chronic lymphocytic leukemia.

Authors:  Pei-Pei Li; Qing-Min Yao; Hui Zhou; Li-Li Feng; Xue-Ling Ge; Xiao Lv; Na Chen; Kang Lu; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 8.  Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.

Authors:  Evan Noch; Kamel Khalili
Journal:  Cancer Biol Ther       Date:  2009-10       Impact factor: 4.742

Review 9.  Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes.

Authors:  Devanand Sarkar; Luni Emdad; Seok-Geun Lee; Byoung Kwon Yoo; Zao-Zhong Su; Paul B Fisher
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

10.  Astrocyte elevated gene-1: a novel target for human glioma therapy.

Authors:  Luni Emdad; Devanand Sarkar; Seok-Geun Lee; Zhao Zhong Su; Byoung Kwon Yoo; Rupesh Dash; Adly Yacoub; Christine E Fuller; Khalid Shah; Paul Dent; Jeffrey N Bruce; Paul B Fisher
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.